Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleReviewsR

De-escalation of Axillary Surgery in the Neoadjuvant Chemotherapy (NACT) Setting for Breast Cancer: Is it Oncologically Safe?

UMAR WAZIR and KEFAH MOKBEL
Anticancer Research October 2020, 40 (10) 5351-5354; DOI: https://doi.org/10.21873/anticanres.14542
UMAR WAZIR
1London Breast Institute, Princess Grace Hospital, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEFAH MOKBEL
1London Breast Institute, Princess Grace Hospital, London, U.K.
2Department of General Surgery, Khyber Teaching Hospital, Peshawar, Pakistan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kefah.mokbel@hotmail.com
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 10 5351-5354
DOI 
https://doi.org/10.21873/anticanres.14542
PubMed 
32988853

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 13, 2020
  • Revision received July 23, 2020
  • Accepted July 24, 2020
  • Published online September 28, 2020.

Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. UMAR WAZIR1 and
  2. KEFAH MOKBEL1,2⇑
  1. 1London Breast Institute, Princess Grace Hospital, London, U.K.
  2. 2Department of General Surgery, Khyber Teaching Hospital, Peshawar, Pakistan
  1. Correspondence to: Prof Kefah Mokbel, London Breast Institute, the Princess Grace Hospital, 45 Nottingham Place, London W1U 5NY, U.K. Tel: +44 2079082040. e-mail: kefah.mokbel{at}hotmail.com
View Full Text

Cited By...

  • 5 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 40 (10)
Anticancer Research
Vol. 40, Issue 10
October 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
De-escalation of Axillary Surgery in the Neoadjuvant Chemotherapy (NACT) Setting for Breast Cancer: Is it Oncologically Safe?
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
14 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
De-escalation of Axillary Surgery in the Neoadjuvant Chemotherapy (NACT) Setting for Breast Cancer: Is it Oncologically Safe?
UMAR WAZIR, KEFAH MOKBEL
Anticancer Research Oct 2020, 40 (10) 5351-5354; DOI: 10.21873/anticanres.14542

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
De-escalation of Axillary Surgery in the Neoadjuvant Chemotherapy (NACT) Setting for Breast Cancer: Is it Oncologically Safe?
UMAR WAZIR, KEFAH MOKBEL
Anticancer Research Oct 2020, 40 (10) 5351-5354; DOI: 10.21873/anticanres.14542
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Current Evidence Outside NACT
    • Regional Node Irradiation as the Only Therapy After Positive SNB
    • Is the SNB a Valid Alternative to cALND in the Context of NACT?
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Sensitivity, Specificity and the Diagnostic Accuracy of PET/CT for Axillary Staging in Patients With Stage I-III Cancer: A Systematic Review of The Literature
  • Google Scholar

More in this TOC Section

  • Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-10
  • Proteolytic Enzyme Therapy in Complementary Oncology: A Systematic Review
  • Multimodal Treatment of Primary Advanced Ovarian Cancer
Show more Reviews

Similar Articles

Keywords

  • Breast cancer
  • neo-adjuvant chemotherapy
  • sentinel node biopsy
  • axillary disease
  • review
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire